TrkB overexpression is linked to metastatic laryngeal cancer cell lines, and it drives EMT by regulating c-Src-mediated activation of PI3K/AKT signal pathway, suggesting the therapeutical opportunity of TrkB to counteract metastasis in the LSC (33). The gene discussed is AKT1; the disease is laryngeal carcinoma.